CRISPR THERAPEUTICS AG COM CHF0.03 earnings per share and revenue

0VRQ earnings per share for the last quarter are -1.43 USD whereas the estimation was -1.36 USD which accounts for -5.08% surprise. Företagets omsättning för samma period uppgår till 504.00 k USD trots den uppskattade siffran 23.05 M USD. Estimated earnings per share for the next quarter are -1.52 USD, and revenue is expected to reach 5.90 M USD. Also watch annual changes over time to get a bigger picture of 0VRQ earnings per share and revenue dynamics.